EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

The Role of JAK2 in Myeloproliferative Diseases Diagnosis

Yudith Annisa Ayu Rezkitha, S. Ugroseno Yudho Bintoro, Ami Ashariati

Biomolecular and Health Science Journal · 2018

DOI: 10.20473/bhsj.v1i2.9831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecular and Health Science Journal, 2018. Verfasst von Yudith Annisa Ayu Rezkitha und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Janus Kinase 2 (JAK2) plays an important role in mediating transduction signal of hematopoiesis, including in the pathogenesis of Myeloproliferative diseases (MPD). Various studies have been carried out to identify the position of aleles in tyrosine encoding mutations. Although the effect of JAK2 mutations is still not fully understood, the discovery of these mutations might be able to differentiate the types of polycythaemia vera, essential thrombocytemia, and primary myelofibrosis with malignant abnormalities. WHO has revised the MPD diagnosis criteria following this finding. This review will discuss the role of JAK2.

Zitieren

APA

Rezkitha, Y. A. A., Bintoro, S. U. Y., & Ashariati, A. (2018). The Role of JAK2 in Myeloproliferative Diseases Diagnosis. Biomolecular and Health Science Journal. https://doi.org/10.20473/bhsj.v1i2.9831

Vancouver

Rezkitha YAA, Bintoro SUY, Ashariati A. The Role of JAK2 in Myeloproliferative Diseases Diagnosis. Biomolecular and Health Science Journal. 2018. doi:10.20473/bhsj.v1i2.9831

BibTeX
@article{Rezkitha2018,
  author = {Rezkitha, Yudith Annisa Ayu and Bintoro, S. Ugroseno Yudho and Ashariati, Ami},
  title = {The Role of JAK2 in Myeloproliferative Diseases Diagnosis},
  journal = {Biomolecular and Health Science Journal},
  year = {2018},
  doi = {10.20473/bhsj.v1i2.9831}
}
Kostenlos starten →